India News | 'Coronil' Cannot Be Used as Medicine in R'than Without AYUSH Ministry's Permission: Raghu Sharma

Get latest articles and stories on India at LatestLY. Amid the ongoing controversy over Yoga guru Baba Ramdev's company Patanjali Ayurveda introducing "cure" for coronavirus infection, Rajasthan government on Wednesday clarified that this drug cannot be not used as a medicine in the state without the permission of the Ministry of AYUSH.

Remdesivir

Jaipur, Jun 24 (PTI) Amid the ongoing controversy over Yoga guru Baba Ramdev's company Patanjali Ayurveda introducing "cure" for coronavirus infection, Rajasthan government on Wednesday clarified that this drug cannot be not used as a medicine in the state without the permission of the Ministry of AYUSH.

Neither has anyone applied to the state government nor has the state government given any permission in this regard, State Health Minister Raghu Sharma said.  

Also Read | Uttar Pradesh | 69 Additional Superintendents of Police Transferred From Their Posts: Live News Breaking & Coronavirus Updates on June 24, 2020.

He said according to the gazette notification issued by the Government of India in April this year, under the Drugs and Cosmetic Act 1940 and 1945, no ayurvedic medicine can sold as medicine for corona infection during COVID-19 pandemic without the approval of Union Ministry of AYUSH. 

Strict action will be taken against the seller as per the rules in case of sale of any drug as a medicine to treat the coronavirus infection, the minister added.

Also Read | COVIFOR, Antiviral Drug For COVID-19 by Indian Pharma Company Hetero, Priced at Rs 5,400 Per 100 Mg Vial in India.

Patanjali Ayurveda, while presenting ''Coronil'' medicine on Tuesday had claimed that it has found a cure for coronavirus infection.

Sharma said compliance of the guidelines of the Union Ministry of Health, Union Ministry of AYUSH and ICMR is being ensured in the treatment of coronavirus infection in the state. 

The health minister said no human clinical test of a drug can be done without the permission of the state government and action will be taken against those who mislead the common people by doing ''clinical trials'' without permission.

Referring to the various guidelines of the central government and other regulatory bodies, Sharma said without their compliance, action will be taken against the publicity and sale of any such means to treat the infection.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now